FWY003, FWY003, Placebo to FWY003, FWY003 clinical trials

A randomized, double masked, placebo-controlled, multicenter, dose-range finding study to assess the efficacy and safety of FWY003 in patients with geographic atrophy secondary to age-related macular degeneration

This study is looking at a new treatment called FWY003 for a common eye condition called geographic atrophy. Researchers want to see if FWY003 can slow down the growth of 'blind spots' in the eye and if it's safe to use. Different doses of the treatment are being tested.